biotherapy for breast cancer

Release time ：Nov-11,2024

Biological therapies for breast cancer typically involve the use of specific drugs that target the mechanisms underlying cancer cell growth and spread by recognizing unique markers on these cells. Such treatments may be particularly effective for certain breast cancer types, notably those that are HER2-positive or hormone receptor-positive.

In a detailed analysis, biological therapies can be categorized into several distinct approaches. Firstly, for HER2-positive breast cancer, one therapy involves the use of monoclonal antibodies to block the function of the HER2 protein, thereby inhibiting cancer cell growth. Secondly, for hormone receptor-positive breast cancer, endocrine therapies can prevent cancer cell growth by either blocking estrogen's action or reducing its production in the body. Additionally, immunotherapy activates the patient's immune system to identify and attack cancer cells. The selection of these treatment methods depends on the patient's tumor type, disease severity, and overall health status.

For daily recommendations, it is crucial for breast cancer patients to undergo regular medical examinations to monitor disease progression. Patients should follow their doctors' guidance and undergo treatment under medical supervision, without independently deciding to start or cease any medication. Maintaining healthy lifestyle habits, such as a balanced diet, regular exercise, and avoiding smoking, can also enhance treatment outcomes and quality of life.